Project Details
Description
PROJECT NARRATIVE
This work targets the inhibition of an enzyme (CK2α’) that is upregulated in the brains of Huntington’s disease
(HD) patients, promoting the degradation of protective proteins. This research will provide an excellent
foundation for the validation of this target as therapeutically relevant in HD, and allow for the future development
of new drugs that halt or reverse the cognitive and motor decline associated with HD.
| Status | Finished |
|---|---|
| Effective start/end date | 2/15/21 → 1/31/23 |
Funding
- National Institute of Neurological Disorders and Stroke: $170,417.00
- National Institute of Neurological Disorders and Stroke: $227,512.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.